These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7349145)

  • 21. [Long-term follow-up and bone imaging in acquired osteochondrodysplasia in a female patient with thalassemia and desferrioxamine hypersensitivity].
    Mangiagli A; De Sanctis V; Campisi S; Di Silvestro G; Urso L
    Minerva Pediatr; 2000 Apr; 52(4):235-41. PubMed ID: 11995208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The mechanism of cataract formation in persons with beta-thalassemia].
    Popescu C; Siganos D; Zanakis E; Padakis A
    Oftalmologia; 1998; 45(4):10-3. PubMed ID: 10418622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term audiological evaluation of beta-thalassemic patients.
    Kontzoglou G; Koussi A; Economou M; Tsatra I; Perifanis V; Noussios G; Athanassiou-Metaxa M
    Acta Otorhinolaryngol Belg; 2004; 58(2):113-7. PubMed ID: 15515654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thalassemic cardiopathy: serial echocardiographic evaluation].
    Bosi S; Spinolo L; Cavallini B; Guadagni C; Lama A; Santarelli R; Baccini C
    G Clin Med; 1982 Apr; 63(4):248-54. PubMed ID: 7128980
    [No Abstract]   [Full Text] [Related]  

  • 25. [Electrocardiographic and radiologic evaluation in cardiac involvement in patients with beta-thalassemia major].
    Lo Jacono F; Agnello D; Malizia R; Maltese I; Marasa' R
    Pediatria (Napoli); 1980 Sep; 88(3):385-93. PubMed ID: 7220158
    [No Abstract]   [Full Text] [Related]  

  • 26. Lens opacities in thalassemia.
    Bloomfield SE; Markenson AL; Miller DR; Peterson CM
    J Pediatr Ophthalmol Strabismus; 1978; 15(3):154-6. PubMed ID: 739345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron excretion in thalassemia after the administration of chelating agents.
    Markum AH; Iskandar W; Keng KL; Odang O
    Paediatr Indones; 1969; 9(3):89-98. PubMed ID: 4981722
    [No Abstract]   [Full Text] [Related]  

  • 28. Early iron chelation therapy in thalassemia major.
    Russo G; Romeo MA; Musumeci S; SchilirĂ² G; Di Gregorio F
    Haematologica; 1983; 68(1):69-73. PubMed ID: 6404710
    [No Abstract]   [Full Text] [Related]  

  • 29. [Respiratory function tests in adolescents with beta-thalassemia major (author's transl)].
    Secchi GC; Scotti PG; Cambiaghi G; Aresini G; De Carli A; Guerrieri MC
    Haematologica; 1982 Feb; 67(1):23-32. PubMed ID: 6800901
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute renal failure following deferoxamine overdose.
    Li Volti S; Maccarone C; Li Volti G; Romeo MA
    Pediatr Nephrol; 2003 Oct; 18(10):1078-9. PubMed ID: 12920634
    [No Abstract]   [Full Text] [Related]  

  • 31. [Severe cardiomyopathy in a woman with intermediate beta-thalassemia. Regression of cardiac failure with desferrioxamine].
    Mancuso L; Iacona MA; Marchi S; Rigano P; Geraci E
    G Ital Cardiol; 1985 Sep; 15(9):916-20. PubMed ID: 4085735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Desferrioxamine in thalassemia].
    Biener R; Freundlich E; Rachmilewitz E
    Harefuah; 1983 May; 104(10):438-40. PubMed ID: 6629159
    [No Abstract]   [Full Text] [Related]  

  • 33. Computed tomography scanning of the liver to determine efficacy of iron chelation therapy in thalassemia major.
    Olivieri NF; Grisaru D; Daneman A; Martin DJ; Rose V; Freedman MH
    J Pediatr; 1989 Mar; 114(3):427-30. PubMed ID: 2921687
    [No Abstract]   [Full Text] [Related]  

  • 34. [Non-invasive methods of study of the cardiopathy of Cooley's disease].
    Colace F; Antimi M; Tozzi Q; Masi M; Fanfera G; Cecconi M; Cianciulli P; Cipriani C; Stipa E; Pratesi G
    Recenti Prog Med; 1984 Mar; 75(3):241-61. PubMed ID: 6233683
    [No Abstract]   [Full Text] [Related]  

  • 35. The management of the improved prognosis in thalassemia major.
    Modell B
    Birth Defects Orig Artic Ser; 1982; 18(7):329-37. PubMed ID: 6819016
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cardiological problems in thalassemia major].
    Mancuso L
    G Ital Cardiol; 1988 Aug; 18(8):665-70. PubMed ID: 3243416
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of deferoxamine on renal function in thalassemia.
    Hyman CB; Gonick HC; Agness C; Nadorra R; Landing B
    Birth Defects Orig Artic Ser; 1988; 23(5B):135-40. PubMed ID: 3390536
    [No Abstract]   [Full Text] [Related]  

  • 38. [Echocardiographic a profile of 92 subjects with thalassemia major].
    Comi LI; De Angelis P; Mastrobuoni A; De Rosa L; Stefanelli S; Lupi L; Petretta V; Giordano E
    Boll Soc Ital Cardiol; 1979; 24(9):1001-18. PubMed ID: 553645
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies of cardiopulmonary and platelet function in thalassemic children.
    Isarangkura P; Chantarojanasiri T; Sudhas Na Ayuthya P; Pintadit P; Hathirat P; Suwanjutha S; Pongpanich B; Sasanakul W
    Birth Defects Orig Artic Ser; 1987; 23(5A):385-93. PubMed ID: 3689922
    [No Abstract]   [Full Text] [Related]  

  • 40. The cardiac manifestations of thalassemia major: natural history, noninvasive cardiac diagnostic studies and results of cardiac catheterization.
    Ehlers KH; Levin AR; Klein AA; Markenson AL; O'Loughlin JE; Engle MA
    Cardiovasc Clin; 1981; 11(2):171-86. PubMed ID: 7214380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.